Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
17.81
+0.38 (2.18%)
At close: Aug 13, 2025, 4:00 PM
17.58
-0.23 (-1.29%)
Pre-market: Aug 14, 2025, 8:34 AM EDT
Elanco Animal Health Employees
As of December 31, 2024, Elanco Animal Health had 9,450 total employees, including 9,000 full-time and 450 part-time employees. The number of employees decreased by 350 or -3.57% compared to the previous year.
Employees
9,450
Change (1Y)
-350
Growth (1Y)
-3.57%
Revenue / Employee
$474,497
Profits / Employee
$45,926
Market Cap
8.85B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ELAN News
- 6 days ago - Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy - Seeking Alpha
- 6 days ago - Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook - Benzinga
- 7 days ago - Elanco Animal Health Reports Second Quarter 2025 Results - PRNewsWire
- 20 days ago - Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs - PRNewsWire
- 5 weeks ago - Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - PRNewsWire
- 5 weeks ago - Elanco's dog flu vaccine gets USDA nod - Reuters
- 5 weeks ago - Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PRNewsWire